Dr. Emir Hadzijusufovic received The City of Vienna Fund for Innovative Interdisciplinary Cancer Research Prize in December 2019. His high impact work entitled: „Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target site“, published 2017 in Leukemia, was awarded EUR 3.500,00.
On Friday, November 8th, 2019 the annual Scientific Advisory Board (SAB) of the LBI HO took place in Vienna.
Thomas Grunt, Deputy Scientific Coordinator of the LBI HO, is Principal Investigator of an award-winning project that aims to elucidate the causal mechanisms of the anticancer effects of compounds that interfere with the cancer cell machinery for production new lipids.
On April 24th 2019 the KickOff Meeting was held to welcome The Children’s Cancer Research Institute (CCRI) as the new partner in the Ludwig Boltzmann Institute for Hematology and Oncology (LBI HO).
On March 20, 2018 the Austrian Society for Stem Cell Research (ASSCR.at) was founded, with the goal of connecting the most important stakeholders of national stem cell research, bundling research activities and exchange between science, patients and physicians.
(c) IMBA
Two highly talented researchers from the hematology department were honored by the Sanofi-Aventis-Award 2017. This award was given to Dr. Barbara Peter and Dr. Katharina Blatt from the Ludwig Boltzmann Institute for Hematology and Oncology (formerly Ludwig Boltzmann Cluster Oncology) coordinated by Prof. Valent, for two publications in renowned scientific journals.
The latest edition of the Blue Book of the WHO, titled the 'Classification of Tumours of Haematopoietic and Lymphoid Tissues', is now available. The basic concept of the classification of mastocytosis has in part been developed in Vienna.
Prof. Peter Valent had the honor to give the Robert Frank Lecture during the opening ceremony of the CED-IADR/NOF Oral Health Resarch Congress on September 21, 2017.
The topic of the lecture was: "Somatic Evolution of Cancer: Cancer Stem Cells and Beyond".
The Ludwig Boltzmann Cluster Oncology (LBC ONC) is happy to welcome the University of Veterinary Medicine Vienna as a new Partner of the Cluster!
In order to celebrate this collaboration, a KickOff Meeting under the motto „Bridging the Gap“ was held.
Aspects of Comparative Oncology relevant to collaborations between the partners of the LBC ONC, including the Vetmeduni Vienna and MedUni Wien were presented.
Several experts from Vienna are represented within the group of leading scientist and top-cited authors in the field of immunology in the German-speaking area. The field of immunology includes many parts of medicine, including allergology, hematology and cancer research. One of the top five cited experts in the field of classic immunology is the scientific coordinator of the LBC ONC, Peter Valent.
The top-citation score is based on the articles from the year 2011 to 2015. Database: 'Web of Science' of the Thomson Reuters-Institute for Scientific Information (ISI).